A once-monthly injection to control HIV proved as effective as daily pills in a second study by GlaxoSmithKline, paving the way for a new regimen that could be simpler for some patients to be filed with regulators.
from Reuters: Health News https://ift.tt/2Psmg7y
via IFTTT
from Reuters: Health News https://ift.tt/2Psmg7y
via IFTTT
إرسال تعليق